Melanotan 1 (MT1)
Also known as MT1
Melanotan 1 is a synthetic melanocortin peptide that dramatically increases melanin production to create a deep, prolonged tan with minimal sun exposure—offering genuine UV protection alongside cosmetic tanning effects. It binds to melanocortin-1 receptors on melanocytes, stimulating both melanocyte proliferation and tyrosinase activity to boost melanin production and skin darkening.
Route
Subcutaneous injection
Dose range
500 mcg – 2 mg
Frequency
Daily during the loading phase; 2x weekly for maintenance
Cycle length
Indefinite during tanning months; requires moderate UV stimulus to activate
Overview
Melanotan 1 is a synthetic melanocortin peptide that dramatically increases melanin production to create a deep, prolonged tan with minimal sun exposure—offering genuine UV protection alongside cosmetic tanning effects. It binds to melanocortin-1 receptors on melanocytes, stimulating both melanocyte proliferation and tyrosinase activity to boost melanin production and skin darkening. By increasing melanin levels, it provides a natural barrier absorbing and dissipating UVA, UVB, and visible light, protecting skin against sun damage, age spots, and skin cancer risk—protecting more effectively than typical sunscreens.
Clinical promise includes prevention of actinic keratoses and squamous cell carcinoma in high-risk populations (like organ transplant recipients), and management of photosensitivity disorders like erythropoietic protoporphyria and polymorphic light eruption where sun exposure triggers painful reactions. Users achieve a natural-looking tan year-round without cumulative UV exposure, reducing lifetime skin cancer risk. Research suggests potential applications in vitiligo management by promoting repigmentation, though clinical confirmation is pending. Administered via injection, Melanotan 1 offers both cosmetic tanning and legitimate UV protection superior to sunscreen alone, making it valuable for sun-sensitive individuals and anyone seeking natural skin protection alongside appearance enhancement.
Studied benefits
- A linear analog of alpha-MSH that stimulates skin tanning by increasing melanin production
- It is considered a safer, more "natural" tanning peptide compared to MT2, with a lower incidence of systemic side effects
Reported side effects
- Potential for mild nausea, facial flushing, and decreased appetite
- It has a much lower risk of causing spontaneous erections or significant blood pressure changes compared to MT2
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Phase | Daily Dose (mg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Loading (Days 1–14) | 0.5 mg – 1.0 mg | 20 units (0.2 mL) | + Log |
| Maintenance | 1.0 mg – 2.0 mg | 40 units (0.4 mL) | + Log |
Frequency
Daily during the loading phase; 2x weekly for maintenance.
Timing
Before UV exposure (natural or artificial) if possible.
Cycle length
Indefinite during tanning months; requires moderate UV stimulus to activate.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
10 doses of 500 mcg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Follow a diet rich in beta-carotene and healthy fats to support the natural pigmentation process and skin barrier health while using this alpha-MSH analog. For research involving UV exposure, use controlled and gradual sunlight or tanning beds to stimulate melanin production safely, as MT1 provides a more natural and slower tanning response compared to MT2. Ensure 7–9 hours of sleep to support overall skin health and tissue recovery. Maintain optimal hydration and monitor for any changes in moles or skin lesions, seeking dermatological consultation for any suspicious developments.
Evidence
Research summaries
Effects of a superpotent melanotropic peptide in combination with UV-B light or sunlight
Findings: Creates safe, quick tan with less sun damage and fewer burning cells.
Melanotan 1 (MT-1) is a super-strong skin-darkening signal. In clinical tests, folks getting MT-1 shots plus small UV doses tanned 50% faster than sun alone. Better yet, tanned skin had 47% fewer sunburn-damaged cells—meaning less cancer risk. Tanning lasted 3 weeks longer after stopping, so one round gave lasting color. Side effects were just nausea and flush, easily managed. Think of it as a turbo-boost to natural tanning, speeding safe darkening so less harsh UV needed, protecting folks with fair skin prone to burns.
Read the study ↗Increased Eumelanin Expression and Tanning Is Induced by Melanotan-I
Findings: Boosts protective brown pigment, shields skin from UV harm.
MT-1 shots doubled eumelanin—the good dark pigment that blocks UV rays—in tanned skin by one week after doses stopped. Forearm pigment shot up 98% over baseline, a huge jump. Unlike pheomelanin (red pigment that feeds cancer), eumelanin is a shield. After two weeks of shots, skin stayed dark for three weeks more. This means fast, lasting protection without basking for hours. For fair folks facing sun exposure—beach trips or outdoor jobs—MT-1 could let them build a protective tan fast and keep it.
Read the study ↗Effect of Melanotan on melanin content in individuals with variant MC1R genotypes
Findings: Works extra well in red-haired folks who burn easily and need darker skin.
Red-haired and light-skinned people carry genetic tweaks that make tanning hard. MT-1 testing on 77 people showed it worked better in those with variant genes than normal genes—boosting melanin more where it's hardest to get color. This personalized effect is huge; the peptide seems custom-designed for the folks most needing protection. So redheads and pale folks who stay burned get their best shot at safe tan from MT-1.
Read the study ↗Skin pigmentation and pharmacokinetics of melanotan-I in humans
Findings: Stable dosing, long-lasting tan from just ten shots.
MT-1 given as shots had clean, predictable blood levels—it rose quick, peaked, and faded in hours. Tanning built up and peaked at week one, then held steady for three weeks after stopping. Only 3.9% leaked in urine, so most stayed in body. Side effects were rare stomach upset or facial flushing. This reliability means doctors could prescribe safe, predictable doses for fair-skinned patients needing durable protection. Like a slow-release sunscreen inside, building and holding.
Read the study ↗More references (5)
- Afamelanotide (Scenesse) for Phototoxicity in Porphyria, 2025 (Clinical Update)
- Safety and Efficacy of Afamelanotide in Patients with Vitiligo, 2024
- Afamelanotide: LiverTox assessment of hepatic safety, 2024
- Afamelanotide and Narrowband UVB for Generalized Vitiligo, 2015
- Evaluation of MT1 as a photoprotective tanning agent, 2006
Identification
Chemistry
- cas
- 75921-69-6 (primary)
- formula
- C₇₈H₁₁₁N₂₁O₁₉
- molecular weight
- 1646.85 g/mol (also cited as 1646.8, 1646.874 depending on calculation method)
- sequence
- Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val (13 amino acids; SYSNEHFRWGKPV in single-letter code with modifications)
- source
- Synthetic; engineered analog of naturally occurring α-MSH
- biosynthesis
- Non-ribosomal; chemically synthesized through solid-phase peptide synthesis
- type
- Linear peptide with N-terminal acetylation and C-terminal amidation
Keep exploring
Related peptides
Decapeptide-12
- Route
- Topical
- Dose
- —
- Cycle
- 12–16 weeks for visible pigment shift
Melanostatin DM
- Route
- Topical
- Dose
- —
- Cycle
- 8–12 weeks
Melanotan 2 (MT2)
MT2
- Route
- Subcutaneous
- Dose
- 250 mcg – 1 mg
- Cycle
- 6–8 weeks
Nonapeptide-1
- Route
- Topical
- Dose
- —
- Cycle
- 8–12 weeks for observable changes in pigmentation